Conditions: 2.5 mg · tirzepatide.
Please show the division. I want to check my own against yours.
I would like the general form as well as the specific number, so I can apply it again.
Where is my error, and what is the correct working?
On a 2.5 mg vial every percentage point of water and counter-ion is 0.025 mg, so the answer is a multiplication once you have the net peptide content off the certificate. Settle first whether the 2.5 mg on the label is gross fill or net peptide, because the two differ by exactly the quantity being asked about. If the certificate quotes net peptide content of 85 per cent, a 2.5 mg gross fill holds 2.13 mg of peptide; at 78 per cent it holds 1.95 mg. That 0.18 mg gap is 7 per cent of the label, larger than any purity difference anybody argues about, and it is invisible to a purity figure because water and acetate are not impurity peaks. Amino acid analysis or a nitrogen determination gives you the number; an HPLC area per cent never will.
The relevant detail is that quantified content is how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard, and it is the only measurement that directly answers that question.
Comparing content results from different laboratories requires knowing whether they both used certified reference materials or whether one used an in-house standard of unknown provenance.
| Δ mass (Da) | Most likely cause | Distinguishing feature |
|---|---|---|
| +1 | Deamidation (Asn or Gln) | New peak, slightly earlier retention |
| −17 | Loss of ammonia | Often with deamidation |
| −18 | Dehydration / succinimide | pH-dependent, reversible |
| +16 | Oxidation (Met, Trp) | Earlier retention, light-related |
| −128 | Missing Gln or Lys | Deletion sequence from synthesis |
| 0 | Isomer: racemisation or scrambling | Same mass, shifted retention |
Concretely, if a sample shows high purity but low content, the explanation is usually that the standard used for quantitation had a different purity than claimed.
The relative standard deviation on replicate quantitations of a homogeneous sample should be below two per cent when the method is under control.
One qualification: a single result from a single vial is a point estimate, and repeating the assay on a second aliquot is worth doing if the first result is surprising.
If a supplier gives you content without the standard's purity, ask them to provide it.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemThe honest answer is that you cannot know for certain what you have without a content assay, and the purity number alone is not enough.
Water content and counter-ion content are part of the gross mass but not part of the content assay result, which is why the two do not sum to label claim.
The part that matters: quantitation against a certified reference material assumes the sample and standard are treated identically through the analytical method, which is why the method for calibration matters as much as the method for measurement.
Worth noting that the standard certificate carries its own uncertainty, usually on the order of two to three per cent, which the sample result inherits.
The practical summary: if you are ordering from a new supplier, budget for content assay on the first lot.
Stated carefully, a high purity does not guarantee high content because it says nothing about how much of anything is in the vial — a vial could be 99 per cent pure but only half full.
System suitability for a quantitative method is stricter than for purity because a small systematic error in the standard directly translates into an error in the sample result.
Running multiple independent aliquots of the same sample should give results that agree to within the method precision, which is usually one to three per cent.
Quantitation against a standard requires that the standard be traceable to a national metrology institute, and certificates for research-grade standards claim that traceability.
The limitation is that a quantitative method is only as good as the standard it uses, and a cheap standard is a false economy.
Ask for both the purity and the content, and do not accept purity alone.
Start from what you are trying to know — whether a vial contains what the label claims — and purity does not answer that question.
The single most common reason for disagreement between a supplier content figure and an independent assay is using different standards.
Pharmacopoeial guidance on quantitative methods specifies validation steps for linearity, range, accuracy and precision that most research-grade work does not claim to meet.
If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.
edited 4 Nov 2024 by birk_nordahl — clarified the distinction between purity and content
On the detail: most research-grade certificates report purity without content, which is exactly backwards from what users actually need.
A content assay is always paired with a purity assay because purity tells you what fraction of the measured mass is the target and content tells you the total measured mass.
Where content data have been published from testing services on common peptides, the spread between services on identical material is typically a few per cent.
I would not rely on a content figure from a lab that is not willing to state their standard's purity on request.
In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.